About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Boston | 158 Studies

Clinical Trials Brain CancerBoston

Brain Cancer Clinical Trials in Boston

Find 158 clinical trials for brain cancer near Boston, Massachusetts. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-158 of 158 trials

CompletedErlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeThis phase II trial is studying how well giving erlotinib together with sorafenib works in treating patients with progressive or recurrent glioblastoma multiforme.NCT00445588·Birmingham, Alabama and 8 others CompletedCOL-3 in Treating Patients With Progressive or Recurrent Brain TumorsRATIONALE: COL-3 may stop the growth of brain tumors by stopping blood flow to the tumor.NCT00004147·Birmingham, Alabama and 8 others RecruitingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisThis multi-site, Phase 1/2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO212 alone for the…NCT06047379·Beverly Hills, California and 7 others

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaThis phase I trial is studying the side effects and best dose of aflibercept when given together with radiation therapy and temozolomide in treating patients with newly diagnosed…NCT00650923·Los Angeles, California and 8 others

CompletedTemozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006358·Los Angeles, California and 10 others

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

Active not recruitingA Study of Abemaciclib in Recurrent GlioblastomaThis research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM). The following intervention will be used in this study: -AbemaciclibNCT02981940·Los Angeles, California and 6 others

CompletedPenicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaRATIONALE: Penicillamine may stop the growth of glioblastomas by stopping blood flow to the tumor. A diet low in copper may interfere with the growth of brain tumor cells.NCT00003751·Birmingham, Alabama and 8 others

CompletedImetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaRATIONALE: Imetelstat sodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01273090·Birmingham, Alabama and 22 others

CompletedLUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent GlioblastomaThis Phase 2 single arm trial in patients with rGBM will characterize the efficacy, safety, tolerability and initial efficacy of lerapolturev intratumoral infusion followed by…NCT04479241·San Francisco, California and 9 others

CompletedCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyThis phase II trial studies how well cilengitide works in treating younger patients with recurrent or progressive high-grade glioma that has not responded to standard therapy.NCT00679354·Oakland, California and 19 others

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

CompletedA Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerThis study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors.NCT03423628·Boston, Massachusetts and 10 others

CompletedEffect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)The study is a prospective, randomly controlled pivotal trial, designed to test the efficacy and safety of a medical device, the NovoTTF-100A, as an adjuvant to the best standard…NCT00916409·Birmingham, Alabama and 88 others

CompletedFimepinostat in Treating Brain Tumors in Children and Young AdultsThis trial studies how well fimepinostat works in treating patients with newly diagnosed diffuse intrinsic pontine glioma, or medulloblastoma, or high-grade glioma that have come…NCT03893487·Los Angeles, California and 18 others

Active not recruitingA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaThe goal of this Phase 3 clinical trial is to compare the efficacy of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed, MGMT unmethylated…NCT06388733·Birmingham, Alabama and 94 others

RecruitingLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionThe goal of this study is to determine the response of the study drug loratinib in treating children who are newly diagnosed high-grade glioma with a fusion in ALK or ROS1.NCT06333899·Aurora, Colorado and 17 others

CompletedValproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS TumorsRATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00107458·Orange, California and 16 others

PreviousPage 8 of 8

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia